ALB and Nephropathy: Patients who received albumin showed longer intervals (18.2 ± 4.3) between procedures, as well as lower rates of both PICD (7 (11.7%)) and kidney damage (6 (10.0%)), which confirmed the therapeutic benefits of albumin.